cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features | Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
AA304826 | colon | .a | 409 to 880 | 1 to 473 | 473/473 (100 %) | 1 diff (99.8 %id) | |||
AA340366 | brain | .a | 671 to 959 | 10 to 298 | 289/298 (96 %) | 6 diff (98.0 %id) | |||
AA378635 | synovial membrane | .a | 532 to 838 | 1 to 307 | 307/307 (100 %) | 0 diff (100 %id) | |||
AJ001340 | .a | 40 to 1554 | 1 to 1515 | exact | 1515/1521 (99 %) | 6 diff (99.7 %id) | |||
AK313696 | .a | 1 to 1501 | 2 to 1502 | exact | tiling clone, | 1502/1502 (100 %) | 0 diff (100 %id) | ||
AW796754 | uterus | .a | 1373 to 1534 | 174 to 11 | 164/174 (94 %) | 2 diff (98.9 %id) | |||
AW797436 | uterus | .a | 653 to 1045 | 424 to 33 | 392/425 (92 %) | 7 diff (98.4 %id) | |||
AW964163 | .a | 533 to 1254 | 1 to 719 | 719/754 (95 %) | 15 diff (98.1 %id) | ||||
AW966844 | .a | 669 to 1254 | 8 to 594 | 587/604 (97 %) | 21 diff (96.6 %id) | ||||
AW970737 | .a | 1134 to 1569 | 444 to 9 | Submitted on the opposite strand | 436/504 (86 %) | 6 diff (98.9 %id) | |||
CB155044 | brain | .a | 326 to 968 | 1 to 643 | 643/643 (100 %) | 0 diff (100 %id) | |||
BC001113 | Skin, melanotic melanoma. | .a | 17 to 1576 | 1 to 1560 | exact | tiling clone, available from MGC, AAA | 1560/1560 (100 %) | 1 diff (100.0 %id) | |
BC009879 | Skin, melanotic melanoma. | .a | 35 to 1577 | 1 to 1543 | exact | available from MGC, AAA | 1543/1543 (100 %) | 1 diff (100.0 %id) | |
BC010048 | Skin, melanotic melanoma. | .a | 17 to 1576 | 1 to 1560 | available from MGC, AAA | 1560/1560 (100 %) | 1 diff (100.0 %id) | ||
BC023662 | Brain, neuroblastoma | .a | 69 to 1577 | 1 to 1509 | exact | available from MGC, AAA | 1509/1509 (100 %) | 0 diff (100 %id) | |
BE171420 | head_neck | .a | 1018 to 1485 | 467 to 1 | Submitted on the opposite strand | 467/467 (100 %) | 1 diff (99.8 %id) | ||
BE171422 | head_neck | .a | 1018 to 1506 | 486 to 2 | Submitted on the opposite strand | 485/486 (99 %) | 0 diff (100 %id) | ||
BE707774 | head_neck | .a | 274 to 550 | 91 to 367 | 277/370 (74 %) | 10 diff (97.3 %id) | |||
BF761735 | colon_est | .a | 300 to 659 | 369 to 13 | Submitted on the opposite strand | 357/369 (96 %) | 0 diff (100 %id) | ||
BG900742 | cartilage | .a | 283 to 592 | 86 to 395 | 310/327 (94 %) | 6 diff (98.2 %id) | |||
BG924772 | cartilage | .a | 404 to 1012 | 78 to 687 | 610/623 (97 %) | 8 diff (98.8 %id) | |||
BX096947 | whole brain | .a | 1092 to 1576 | 499 to 15 | AAA | 485/485 (100 %) | 0 diff (100 %id) | ||
BX281518 | testis | .a | 1146 to 1575 | 458 to 29 | AAA | Submitted on the opposite strand | 430/430 (100 %) | 0 diff (100 %id) | |
BX425873 | neuroblastoma | .a | 778 to 1551 | 774 to 1 | fully sequenced, | 774/774 (100 %) | 7 diff (99.1 %id) | ||
BX447203 | neuroblastoma | .a | 77 to 839 | 1 to 763 | fully sequenced, | 763/763 (100 %) | 1 diff (99.9 %id) | ||
CN287105 | embryonic stem cells, cell lines H1, H7, andH9 | .b | 1 to 681 | 13 to 693 | tiling clone, | 681/693 (98 %) | 6 diff (99.2 %id) | ||
CN287106 | embryonic stem cells, cell lines H1, H7, andH9 | .a | 44 to 752 | 1 to 709 | 709/709 (100 %) | 3 diff (99.6 %id) | |||
CN287107 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .a | 507 to 1098 | 1 to 592 | 592/592 (100 %) | 2 diff (99.7 %id) | |||
BY999740 | .a | 1006 to 1548 | 1 to 543 | Submitted on the opposite strand | 543/547 (99 %) | 2 diff (99.7 %id) | |||
CR598977 | Neuroblastoma Cot 25-normalized | .a | 37 to 1534 | 1 to 1498 | exact | 1498/1498 (100 %) | 0 diff (100 %id) | ||
CR609263 | neuroblastoma | .a | 77 to 1551 | 1 to 1475 | 1475/1475 (100 %) | 0 diff (100 %id) | |||
CR618123 | HeLa cells Cot 25-normalized | .a | 37 to 1548 | 1 to 1512 | exact | 1512/1512 (100 %) | 0 diff (100 %id) | ||
AL525986 | brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized | .a | 844 to 1534 | 691 to 1 | fully sequenced, | 691/691 (100 %) | 0 diff (100 %id) | ||
AL526038 | brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized | .a | 45 to 874 | 8 to 837 | fully sequenced, | 830/837 (99 %) | 10 diff (98.9 %id) | ||
BX435732 | B cells (Ramos cell line) | .a | 1303 to 1573 | 272 to 1 | fully sequenced, | 272/272 (100 %) | 1 diff (99.7 %id) | ||
BX452287 | B cells (Ramos cell line) | .a | 910 to 1574 | 1 to 667 | fully sequenced, | 667/667 (100 %) | 6 diff (99.2 %id) | ||
AL556707 | placenta | .a | 45 to 839 | 8 to 801 | fully sequenced, | 794/801 (99 %) | 7 diff (99.2 %id) | ||
AL578907 | placenta | .a | 778 to 1548 | 770 to 1 | fully sequenced, | 770/770 (100 %) | 2 diff (99.8 %id) | ||
EC451999 | Prostate | .a | 1081 to 1170 | 92 to 4 | 89/92 (96 %) | 0 diff (100 %id) | |||
EC461220 | Prostate | .a | 1115 to 1207 | 91 to 1 | 91/95 (95 %) | 2 diff (97.9 %id) | |||
EC477031 | Prostate | .a | 1115 to 1207 | 93 to 1 | 93/98 (94 %) | 0 diff (100 %id) | |||
EC477784 | Prostate | .a | 1033 to 1123 | 91 to 1 | 91/91 (100 %) | 0 diff (100 %id) | |||
EC489435 | Prostate | .a | 1506 to 1576 | 1 to 71 | 71/73 (97 %) | 1 diff (98.7 %id) | |||
EC506803 | Prostate | .a | 1033 to 1125 | 94 to 1 | 94/94 (100 %) | 0 diff (100 %id) | |||
EC506981 | Prostate | .a | 1033 to 1107 | 92 to 17 | 76/92 (82 %) | 0 diff (100 %id) | |||
EC518490 | Prostate | .a | 1506 to 1576 | 1 to 70 | 70/72 (97 %) | 2 diff (97.3 %id) | |||
EC520874 | Prostate | .a | 1115 to 1207 | 93 to 1 | 93/98 (94 %) | 0 diff (100 %id) | |||
EC535094 | Prostate | .a | 1115 to 1207 | 93 to 1 | 93/97 (95 %) | 0 diff (100 %id) | |||
EC562280 | Prostate | .a | 1506 to 1576 | 1 to 71 | 71/73 (97 %) | 1 diff (98.7 %id) | |||
EC577810 | Prostate | .a | 1115 to 1207 | 91 to 1 | 91/95 (95 %) | 2 diff (97.9 %id) | |||
ES313682 | beard hair, skin | .a | 1056 to 1554 | 1 to 499 | 499/499 (100 %) | 0 diff (100 %id) | |||
DB457319 | testis | .a | 35 to 502 | 1 to 468 | 468/468 (100 %) | 1 diff (99.8 %id) | |||
DB522778 | testis | .a | 1116 to 1575 | 1 to 460 | Submitted on the opposite strand | 460/460 (100 %) | 0 diff (100 %id) | ||
R19456 | whole brain | .a | 62 to 450 | 1 to 390 | 388/391 (99 %) | 20 diff (94.9 %id) | |||
R44705 | whole brain | .a | 1266 to 1577 | 330 to 18 | AAA | 313/313 (100 %) | 3 diff (99.1 %id) | ||
H67809 | liver and spleen | .a | 722 to 1144 | 1 to 428 | 426/428 (99 %) | 12 diff (97.2 %id) | |||
H68081 | liver and spleen | .a | 1275 to 1574 | 301 to 1 | 301/302 (99 %) | 5 diff (98.4 %id) | |||
AA485435 | ovarian tumor, ovary | .a | 1377 to 1578 | 206 to 5 | fully sequenced, | 202/206 (98 %) | 0 diff (100 %id) | ||
AA485600 | ovarian tumor, ovary | .a | 1291 to 1578 | 1 to 286 | fully sequenced, | 288/288 (100 %) | 5 diff (98.3 %id) | ||
AA465355 | germinal center B cell | .a | 1182 to 1581 | 407 to 9 | 399/407 (98 %) | 2 diff (99.6 %id) | |||
AA465426 | germinal center B cell | .a | 629 to 1039 | 1 to 409 | 409/409 (100 %) | 8 diff (98.1 %id) | |||
AA774174 | .a | 1217 to 1576 | 359 to 1 | 359/359 (100 %) | 3 diff (99.2 %id) | ||||
AA494416 | colon | .a | 1363 to 1578 | 217 to 2 | 216/217 (99 %) | 0 diff (100 %id) | |||
AA527453 | colon | .a | 1167 to 1577 | 429 to 18 | AAA | 412/412 (100 %) | 3 diff (99.3 %id) | ||
AA514791 | colon | .e-u | 535 to 733 | 200 to 2 | 199/200 (99 %) | 0 diff (100 %id) | |||
AA599726 | .a | 1195 to 1578 | 386 to 4 | 383/386 (99 %) | 1 diff (99.8 %id) | ||||
AA766812 | germinal center B cell | .a | 169 to 537 | 1 to 362 | Submitted on the opposite strand | 365/362 (100 %) | 15 diff (95.9 %id) | ||
AA741166 | germinal center B cell | .a | 1305 to 1552 | 248 to 1 | 248/248 (100 %) | 3 diff (98.8 %id) | |||
AA907752 | pooled | .a | 1336 to 1576 | 248 to 8 | 241/248 (97 %) | 0 diff (100 %id) | |||
AI081038 | breast | .a | 1117 to 1575 | 459 to 1 | 459/459 (100 %) | 5 diff (99.0 %id) | |||
AI038895 | senescent fibroblast | .a | 1003 to 1576 | 580 to 7 | 574/582 (98 %) | 2 diff (99.7 %id) | |||
AI085341 | anaplastic oligodendroglioma, brain | .e-u | 301 to 735 | 450 to 16 | tiling clone, AAA | 435/435 (100 %) | 0 diff (100 %id) | ||
AI365651 | brain, oligodendroglioma | .a | 1082 to 1547 | 466 to 1 | 466/466 (100 %) | 0 diff (100 %id) | |||
AI571096 | moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus | .g | 1 to 144 | 144 to 1 | exact | tiling clone, | 144/144 (100 %) | 0 diff (100 %id) | |
AI687927 | poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus | .a | 1233 to 1496 | 264 to 1 | 264/265 (99 %) | 20 diff (92.5 %id) | |||
AI916572 | Kidney | .a | 948 to 1578 | 643 to 16 | AAA | 628/629 (99 %) | 7 diff (98.9 %id) | ||
AI703439 | carcinoid, lung | .a | 434 to 709 | 276 to 1 | 276/276 (100 %) | 0 diff (100 %id) | |||
AI695604 | colon | .a | 1205 to 1577 | 393 to 18 | AAA | 376/382 (98 %) | 20 diff (94.8 %id) | ||
AI718049 | aorta | .a | 911 to 1570 | 655 to 1 | 655/655 (100 %) | 11 diff (98.4 %id) | |||
AW007535 | anaplastic oligodendroglioma, brain | .a | 1110 to 1575 | 468 to 2 | 467/468 (99 %) | 1 diff (99.8 %id) | |||
AW297793 | .a | 45 to 541 | 1 to 497 | Submitted on the opposite strand | 497/497 (100 %) | 1 diff (99.8 %id) | |||
BE299514 | muscle, rhabdomyosarcoma | .a | 716 to 1526 | 803 to 1 | fully sequenced, | 803/803 (100 %) | 19 diff (97.7 %id) | ||
BE299896 | muscle, rhabdomyosarcoma | .a | 90 to 741 | 1 to 653 | fully sequenced, | 651/651 (100 %) | 9 diff (98.7 %id) | ||
BE019187 | muscle, rhabdomyosarcoma | .a | 142 to 588 | 1 to 447 | 447/532 (84 %) | 22 diff (95.9 %id) | |||
AW779925 | Kidney | .a | 1130 to 1577 | 448 to 1 | 448/454 (98 %) | 8 diff (98.3 %id) | |||
BE276716 | melanotic melanoma, skin | .a | 7 to 712 | 19 to 727 | 709/796 (89 %) | 14 diff (98.3 %id) | |||
AW406648 | lymph | .a | 94 to 363 | 1 to 270 | 270/270 (100 %) | 5 diff (98.2 %id) | |||
BE047241 | ovary, serous papillary tumor | .a | 992 to 1576 | 588 to 5 | 584/588 (99 %) | 7 diff (98.9 %id) | |||
BE328058 | carcinoid, lung | .a | 396 to 742 | 347 to 1 | 347/350 (99 %) | 6 diff (98.3 %id) | |||
CB047494 | Kidney | .a | 1493 to 1576 | 133 to 50 | AAA | 84/84 (100 %) | 3 diff (96.5 %id) | ||
CB047495 | Kidney | .a | 1145 to 1208 | 10 to 73 | 64/73 (87 %) | 6 diff (91.8 %id) | |||
BE255078 | eye, retinoblastoma | .a | 457 to 1056 | 1 to 602 | 602/602 (100 %) | 2 diff (99.7 %id) | |||
BE258125 | eye, retinoblastoma | .a | 458 to 1036 | 1 to 579 | 580/819 (70 %) | 11 diff (98.7 %id) | |||
BE311436 | Kidney, renal cell adenocarcinoma | .a | 79 to 640 | 1 to 563 | 563/563 (100 %) | 1 diff (99.9 %id) | |||
BE314461 | brain, neuroblastoma | .a | 1 to 679 | 29 to 707 | 679/709 (95 %) | 9 diff (98.8 %id) | |||
BF197711 | carcinoid, lung | .a | 1163 to 1496 | 334 to 1 | 334/334 (100 %) | 16 diff (95.3 %id) | |||
BE384146 | melanotic melanoma, skin | .a | 60 to 702 | 1 to 640 | 640/644 (99 %) | 7 diff (99.0 %id) | |||
BE383924 | melanotic melanoma, skin | .a | 58 to 704 | 1 to 647 | 647/647 (100 %) | 0 diff (100 %id) | |||
BE407874 | choriocarcinoma, placenta | .a | 106 to 716 | 1 to 607 | 607/637 (95 %) | 10 diff (98.5 %id) | |||
BE409604 | choriocarcinoma, placenta | .a | 29 to 814 | 1 to 787 | 787/959 (82 %) | 18 diff (98.2 %id) | |||
BC021032 | Skin, melanotic melanoma. | .a | 17 to 1576 | 1 to 1560 | G305R E454K | available from MGC, AAA | 1560/1560 (100 %) | 3 diff (99.9 %id) | |
BE730304 | melanotic melanoma, skin | .a | 10 to 796 | 27 to 801 | 778/1022 (76 %) | 41 diff (96.0 %id) | |||
BE730313 | melanotic melanoma, skin | .a | 89 to 909 | 27 to 838 | 812/849 (95 %) | 26 diff (97.0 %id) | |||
BE782561 | eye, retinoblastoma | .a | 204 to 801 | 1 to 598 | 598/907 (65 %) | 17 diff (98.2 %id) | |||
BE781261 | eye, retinoblastoma | .c | 1 to 732 | 1 to 729 | K58E P59A E60* | tiling clone, | 729/922 (79 %) | 17 diff (98.2 %id) | |
BF026901 | melanotic melanoma, skin | .a | 55 to 809 | 1 to 747 | 747/807 (92 %) | 13 diff (98.4 %id) | |||
BF026906 | melanotic melanoma, skin | .a | 54 to 798 | 1 to 737 | 737/737 (100 %) | 13 diff (98.3 %id) | |||
BF125138 | melanotic melanoma, skin | .a | 54 to 675 | 1 to 620 | 620/901 (68 %) | 15 diff (98.4 %id) | |||
BF213172 | bone marrow, from acute myelogenous leukemia | .a | 1148 to 1575 | 1 to 428 | 428/622 (68 %) | 3 diff (99.6 %id) | |||
BG334409 | melanotic melanoma, skin | .a | 99 to 810 | 1 to 713 | 713/862 (82 %) | 11 diff (98.8 %id) | |||
BG475421 | melanotic melanoma, skin | .a | 34 to 692 | 1 to 663 | 663/663 (100 %) | 14 diff (97.9 %id) | |||
BG472009 | eye, retinoblastoma | .a | 66 to 713 | 1 to 654 | 654/792 (82 %) | 24 diff (97.0 %id) | |||
BI199622 | brain, neuroblastoma | .a | 79 to 414 | 11 to 344 | 336/346 (97 %) | 26 diff (92.5 %id) | |||
BG825193 | muscle, rhabdomyosarcoma | .a | 23 to 575 | 1 to 552 | 552/552 (100 %) | 2 diff (99.7 %id) | |||
BG830663 | epithelioid carcinoma cell line, Pancreas | .a | 47 to 766 | 1 to 724 | 724/728 (99 %) | 12 diff (98.4 %id) | |||
BI255240 | cervical carcinoma cell line, cervix | .a | 50 to 812 | 1 to 771 | 771/863 (89 %) | 15 diff (98.3 %id) | |||
BI761049 | pooled colon, kidney, stomach | .a | 85 to 977 | 1 to 894 | 894/894 (100 %) | 12 diff (98.7 %id) | |||
BI912074 | leukocyte | .a | 548 to 1024 | 30 to 523 | 494/731 (67 %) | 32 diff (95.7 %id) | |||
BI909178 | leukocyte | .a | 60 to 661 | 1 to 608 | 608/609 (99 %) | 14 diff (97.8 %id) | |||
BI562153 | testis | .a | 28 to 809 | 1 to 782 | 782/825 (94 %) | 12 diff (98.6 %id) | |||
BI561814 | testis | .a | 28 to 672 | 1 to 658 | 658/788 (83 %) | 85 diff (89.3 %id) | |||
BM020244 | astrocytoma grade IV, cell line, brain | .a | 505 to 1124 | 1 to 629 | 629/629 (100 %) | 10 diff (98.5 %id) | |||
BM045451 | carcinoma, cell line, Prostate | .a | 46 to 905 | 1 to 874 | 791/874 (90 %) | 35 diff (96.0 %id) | |||
BM011323 | brain, neuroblastoma, cell line | .a | 45 to 637 | 1 to 601 | 601/601 (100 %) | 13 diff (97.9 %id) | |||
BM912561 | amelanotic melanoma, cell line, skin | .a | 90 to 591 | 1 to 502 | 502/1236 (40 %) | 3 diff (99.8 %id) | |||
BM913079 | amelanotic melanoma, cell line, skin | .a | 113 to 565 | 1 to 453 | 453/1273 (35 %) | 7 diff (99.5 %id) | |||
BM559672 | amelanotic melanoma, cell line, skin | .a | 89 to 797 | 1 to 716 | 716/1057 (67 %) | 16 diff (98.5 %id) | |||
BM915522 | amelanotic melanoma, cell line, skin | .a | 65 to 1043 | 1 to 992 | 992/1042 (95 %) | 18 diff (98.3 %id) | |||
BM460403 | eye, retinoblastoma | .a | 71 to 418 | 1 to 352 | 352/1160 (30 %) | 10 diff (99.2 %id) | |||
BM423437 | amelanotic melanoma, cell line, skin | .a | 1075 to 1577 | 1 to 503 | AAA | 503/503 (100 %) | 0 diff (100 %id) | ||
BM808480 | ovary (pool of 3) | .f | 1 to 566 | 12 to 579 | E26D K35E L36G R37A A39G ... | tiling clone, | 568/1167 (48 %) | 16 diff (98.7 %id) | |
BM126478 | Islets of Langerhans, Pancreas | .a | 845 to 1417 | 1 to 573 | 573/573 (100 %) | 1 diff (99.9 %id) | |||
CK819050 | Islets of Langerhans, Pancreas | .a | 829 to 1420 | 1 to 592 | 592/592 (100 %) | 0 diff (100 %id) | |||
BM805678 | brain, hippocampus | .a | 59 to 716 | 125 to 782 | 658/1154 (57 %) | 14 diff (98.8 %id) | |||
BM924986 | pooled lung and spleen | .a | 930 to 1574 | 1 to 644 | 644/1132 (56 %) | 5 diff (99.6 %id) | |||
BQ003291 | Chondrosarcoma, Left Pelvis | .a | 990 to 1575 | 602 to 19 | AAA | 584/584 (100 %) | 8 diff (98.7 %id) | ||
BQ212932 | melanotic melanoma, skin | .a | 307 to 1108 | 1 to 806 | 806/870 (92 %) | 14 diff (98.4 %id) | |||
BQ086359 | Islets of Langerhans, Pancreas | .a | 1055 to 1575 | 1 to 521 | fully sequenced, | 521/521 (100 %) | 0 diff (100 %id) | ||
BQ102428 | Islets of Langerhans, Pancreas | .a | 1303 to 1576 | 286 to 13 | fully sequenced, AAA | 274/274 (100 %) | 1 diff (99.7 %id) | ||
BU187197 | eye, retinoblastoma | .a | 88 to 801 | 9 to 740 | 730/919 (79 %) | 29 diff (96.9 %id) | |||
BU178670 | eye, retinoblastoma | .a | 78 to 976 | 6 to 907 | 902/917 (98 %) | 27 diff (97.1 %id) | |||
BQ722461 | sympathetic trunk | .a | 1398 to 1578 | 1 to 181 | AAA | 181/181 (100 %) | 0 diff (100 %id) | ||
BQ689506 | ductal carcinoma, cell line, Pancreas | .a | 14 to 589 | 1 to 575 | 575/896 (64 %) | 13 diff (98.6 %id) | |||
BU848786 | ovary, teratocarcinoma, cell line | .a | 14 to 809 | 1 to 798 | 798/931 (85 %) | 6 diff (99.4 %id) | |||
CX165332 | human embryonic stem cells differentiated toan early endodermal cell type | .a | 110 to 880 | 1 to 771 | 771/771 (100 %) | 0 diff (100 %id) | |||
CX757053 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .a | 162 to 801 | 1 to 635 | Submitted on the opposite strand | 635/751 (84 %) | 12 diff (98.5 %id) | ||
CX756032 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .a | 70 to 763 | 1 to 692 | Submitted on the opposite strand | 692/693 (99 %) | 12 diff (98.3 %id) | ||
CD252042 | White Matter | .a | 82 to 594 | 1 to 514 | 514/886 (58 %) | 4 diff (99.6 %id) | |||
CF126098 | Chondrosarcoma Lung Metastasis cell lines, lung | .b | 121 to 950 | 1 to 828 | tiling clone, | 828/828 (100 %) | 3 diff (99.7 %id) | ||
DA603762 | .a | 1 to 515 | 2 to 517 | capped | 516/516 (100 %) | 1 diff (99.9 %id) | |||
TI_57150855 | .a | 85 to 909 | 68 to 892 | 825/961 (85 %) | 14 diff (98.6 %id) | ||||
TI_57236346 | .a | 548 to 1024 | 30 to 523 | AAA | 494/717 (68 %) | 32 diff (95.6 %id) | |||
TI_57236743 | .a | 62 to 661 | 31 to 636 | 606/637 (95 %) | 15 diff (97.7 %id) | ||||
TI_44350065 | .a | 26 to 672 | 121 to 780 | 660/910 (72 %) | 85 diff (90.7 %id) | ||||
TI_44350130 | .a | 26 to 809 | 120 to 903 | 784/946 (82 %) | 12 diff (98.8 %id) | ||||
TI_59380482 | .a | 46 to 637 | 56 to 655 | 600/600 (100 %) | 12 diff (98.0 %id) | ||||
TI_59391028 | .a | 504 to 1124 | 111 to 740 | 630/630 (100 %) | 10 diff (98.5 %id) | ||||
BP430644 | .a | 726 to 1096 | 1 to 372 | 372/372 (100 %) | 5 diff (98.7 %id) | ||||
NM_004704.3 | .a | 35 to 1577 | 1 to 1543 | exact | RefSeq, AAA | 1543/1543 (100 %) | 1 diff (100.0 %id) | ||
CR982861 | T-Lymphocytes | .d-u | 469 to 1204 | 1 to 736 | exact | tiling clone, | 736/738 (99 %) | 1 diff (99.9 %id) | |
BM738183 | Ascites, stomach | .a | 55 to 660 | 1 to 603 | 605/603 (100 %) | 9 diff (98.6 %id) | |||
BM756036 | Ascites, stomach | .a | 55 to 572 | 1 to 518 | 518/518 (100 %) | 0 diff (100 %id) | |||
BM772005 | stomach | .a | 576 to 1173 | 1 to 597 | 597/597 (100 %) | 1 diff (99.9 %id) | |||
BM772454 | stomach | .a | 576 to 1271 | 1 to 695 | 695/695 (100 %) | 1 diff (99.9 %id) | |||
BM825100 | Ascites, stomach | .a | 1059 to 1576 | 534 to 17 | AAA | Submitted on the opposite strand | 518/518 (100 %) | 3 diff (99.5 %id) | |
BM825741 | Ascites, stomach | .a | 312 to 733 | 1 to 422 | 422/422 (100 %) | 0 diff (100 %id) | |||
BP348533 | brain | .a | 38 to 608 | 1 to 573 | 573/573 (100 %) | 4 diff (99.4 %id) | |||
BP348561 | brain | .a | 38 to 620 | 1 to 583 | 583/583 (100 %) | 13 diff (97.8 %id) | |||
T15892 | .a | 1333 to 1577 | 245 to 1 | 245/294 (83 %) | 1 diff (99.7 %id) | ||||
DR006521 | Spleen | .a | 45 to 752 | 20 to 728 | 709/728 (97 %) | 7 diff (99.1 %id) | |||
DB163113 | thymus | .d-u | 1 to 589 | 2 to 590 | tiling clone, capped | 589/589 (100 %) | 0 diff (100 %id) | ||
TI_149288534 | .a | 877 to 1578 | 805 to 105 | AAA | 701/701 (100 %) | 5 diff (99.3 %id) | |||
TI_149301023 | .a | 718 to 1578 | 935 to 85 | AAA | 851/975 (87 %) | 15 diff (98.5 %id) | |||
TI_154008185 | .a | 911 to 1578 | 807 to 145 | AAA | 663/903 (73 %) | 32 diff (96.5 %id) | |||
TI_154188938 | .b | 121 to 1084 | 46 to 1002 | tiling clone, | 957/1028 (93 %) | 17 diff (98.4 %id) | |||
BM970376 | lung | .a | 942 to 1578 | 655 to 19 | AAA | 637/637 (100 %) | 4 diff (99.4 %id) | ||
BM976987 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .a | 957 to 1578 | 640 to 19 | AAA | 622/622 (100 %) | 0 diff (100 %id) | ||
CB243525 | Human Lung Epithelial cells, lung | .a | 854 to 1573 | 737 to 19 | AAA | 719/722 (99 %) | 2 diff (99.8 %id) | ||
BM676339 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 1303 to 1575 | 291 to 19 | fully sequenced, AAA | 273/273 (100 %) | 0 diff (100 %id) | ||
BM712593 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 1014 to 1575 | 1 to 562 | fully sequenced, AAA | 562/562 (100 %) | 0 diff (100 %id) | ||
BU624141 | cell lines, Enchondroma | .a | 929 to 1577 | 667 to 19 | AAA | 649/649 (100 %) | 1 diff (99.9 %id) | ||
BU631813 | cell lines, Chondrosarcoma | .a | 1141 to 1578 | 456 to 19 | AAA | 438/438 (100 %) | 9 diff (98.0 %id) | ||
BU622988 | cell lines, Chondrosarcoma | .a | 957 to 1576 | 638 to 19 | AAA | 620/620 (100 %) | 0 diff (100 %id) | ||
CA432688 | cell lines, Chondrosarcoma | .e-u | 1 to 737 | 754 to 19 | G8X G12V L13S Q14R G15A ... | tiling clone, AAA | 736/736 (100 %) | 2 diff (99.8 %id) | |
AW134863 | .a | 845 to 1417 | 1 to 573 | AAA | Suspected internal deletion, this clone was ignored | 573/573 (100 %) | 1 diff (99.9 %id) | ||
BU165708 | testis | .a | 829 to 1420 | 1 to 592 | Suspected internal deletion, this clone was ignored | 592/592 (100 %) | 0 diff (100 %id) | ||
BQ692008 | ductal carcinoma, cell line, Pancreas | .a | 829 to 1420 | 1 to 592 | Suspected internal deletion, this clone was ignored | 592/592 (100 %) | 0 diff (100 %id) | ||
BM805678 | brain, hippocampus | .a | 59 to 716 | 125 to 782 | 658/1154 (57 %) | 14 diff (98.8 %id) | |||
BM805678 | brain, hippocampus | .a | 59 to 716 | 125 to 782 | 658/1154 (57 %) | 14 diff (98.8 %id) | |||
BM924986 | pooled lung and spleen | .a | 930 to 1574 | 1 to 644 | 644/1132 (56 %) | 5 diff (99.6 %id) | |||
BQ003291 | Chondrosarcoma, Left Pelvis | .a | 990 to 1575 | 602 to 19 | AAA | 584/584 (100 %) | 8 diff (98.7 %id) | ||
BQ003291 | Chondrosarcoma, Left Pelvis | .a | 990 to 1575 | 602 to 19 | AAA | 584/584 (100 %) | 8 diff (98.7 %id) | ||
BQ212932 | melanotic melanoma, skin | .a | 307 to 1108 | 1 to 806 | 806/870 (92 %) | 14 diff (98.4 %id) | |||
BQ212932 | melanotic melanoma, skin | .a | 307 to 1108 | 1 to 806 | 806/870 (92 %) | 14 diff (98.4 %id) | |||
BQ086359 | Islets of Langerhans, Pancreas | .a | 1055 to 1575 | 1 to 521 | fully sequenced, | 521/521 (100 %) | 0 diff (100 %id) | ||
BQ086359 | Islets of Langerhans, Pancreas | .a | 1055 to 1575 | 1 to 521 | fully sequenced, | 521/521 (100 %) | 0 diff (100 %id) | ||
BQ102428 | Islets of Langerhans, Pancreas | .a | 1303 to 1576 | 286 to 13 | fully sequenced, AAA | 274/274 (100 %) | 1 diff (99.7 %id) | ||
BQ102428 | Islets of Langerhans, Pancreas | .a | 1303 to 1576 | 286 to 13 | fully sequenced, AAA | 274/274 (100 %) | 1 diff (99.7 %id) | ||
BU187197 | eye, retinoblastoma | .a | 88 to 801 | 9 to 740 | 730/919 (79 %) | 29 diff (96.9 %id) | |||
BU187197 | eye, retinoblastoma | .a | 88 to 801 | 9 to 740 | 730/919 (79 %) | 29 diff (96.9 %id) | |||
BU178670 | eye, retinoblastoma | .a | 78 to 976 | 6 to 907 | 902/917 (98 %) | 27 diff (97.1 %id) | |||
BU178670 | eye, retinoblastoma | .a | 78 to 976 | 6 to 907 | 902/917 (98 %) | 27 diff (97.1 %id) | |||
BQ722461 | sympathetic trunk | .a | 1398 to 1578 | 1 to 181 | AAA | 181/181 (100 %) | 0 diff (100 %id) | ||
BQ689506 | ductal carcinoma, cell line, Pancreas | .a | 14 to 589 | 1 to 575 | 575/896 (64 %) | 13 diff (98.6 %id) | |||
BQ689506 | ductal carcinoma, cell line, Pancreas | .a | 14 to 589 | 1 to 575 | 575/896 (64 %) | 13 diff (98.6 %id) | |||
BU848786 | ovary, teratocarcinoma, cell line | .a | 14 to 809 | 1 to 798 | 798/931 (85 %) | 6 diff (99.4 %id) | |||
BU848786 | ovary, teratocarcinoma, cell line | .a | 14 to 809 | 1 to 798 | 798/931 (85 %) | 6 diff (99.4 %id) | |||
CX165332 | human embryonic stem cells differentiated toan early endodermal cell type | .a | 110 to 880 | 1 to 771 | 771/771 (100 %) | 0 diff (100 %id) | |||
CX757053 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .a | 162 to 801 | 1 to 635 | Submitted on the opposite strand | 635/751 (84 %) | 12 diff (98.5 %id) | ||
CX757053 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .a | 162 to 801 | 1 to 635 | Submitted on the opposite strand | 635/751 (84 %) | 12 diff (98.5 %id) | ||
CX756032 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .a | 70 to 763 | 1 to 692 | Submitted on the opposite strand | 692/693 (99 %) | 12 diff (98.3 %id) | ||
CX756032 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .a | 70 to 763 | 1 to 692 | Submitted on the opposite strand | 692/693 (99 %) | 12 diff (98.3 %id) | ||
CD252042 | White Matter | .a | 82 to 594 | 1 to 514 | 514/886 (58 %) | 4 diff (99.6 %id) | |||
CF126098 | Chondrosarcoma Lung Metastasis cell lines, lung | .b | 121 to 950 | 1 to 828 | tiling clone, | 828/828 (100 %) | 3 diff (99.7 %id) | ||
CF126098 | Chondrosarcoma Lung Metastasis cell lines, lung | .b | 121 to 950 | 1 to 828 | tiling clone, | 828/828 (100 %) | 3 diff (99.7 %id) | ||
DA603762 | .a | 1 to 515 | 2 to 517 | capped | 516/516 (100 %) | 1 diff (99.9 %id) | |||
TI_57150855 | .a | 85 to 909 | 68 to 892 | 825/961 (85 %) | 14 diff (98.6 %id) | ||||
TI_57236346 | .a | 548 to 1024 | 30 to 523 | AAA | 494/717 (68 %) | 32 diff (95.6 %id) | |||
TI_57236743 | .a | 62 to 661 | 31 to 636 | 606/637 (95 %) | 15 diff (97.7 %id) | ||||
TI_44350065 | .a | 26 to 672 | 121 to 780 | 660/910 (72 %) | 85 diff (90.7 %id) | ||||
TI_44350130 | .a | 26 to 809 | 120 to 903 | 784/946 (82 %) | 12 diff (98.8 %id) | ||||
TI_59380482 | .a | 46 to 637 | 56 to 655 | 600/600 (100 %) | 12 diff (98.0 %id) | ||||
TI_59391028 | .a | 504 to 1124 | 111 to 740 | 630/630 (100 %) | 10 diff (98.5 %id) | ||||
BP430644 | .a | 726 to 1096 | 1 to 372 | 372/372 (100 %) | 5 diff (98.7 %id) | ||||
NM_004704.3 | .a | 35 to 1577 | 1 to 1543 | exact | RefSeq, AAA | 1543/1543 (100 %) | 1 diff (100.0 %id) | ||
CR982861 | T-Lymphocytes | .d-u | 469 to 1204 | 1 to 736 | exact | tiling clone, | 736/738 (99 %) | 1 diff (99.9 %id) | |
BM738183 | Ascites, stomach | .a | 55 to 660 | 1 to 603 | 605/603 (100 %) | 9 diff (98.6 %id) | |||
BM738183 | Ascites, stomach | .a | 55 to 660 | 1 to 603 | 605/603 (100 %) | 9 diff (98.6 %id) | |||
BM756036 | Ascites, stomach | .a | 55 to 572 | 1 to 518 | 518/518 (100 %) | 0 diff (100 %id) | |||
BM756036 | Ascites, stomach | .a | 55 to 572 | 1 to 518 | 518/518 (100 %) | 0 diff (100 %id) | |||
BM772005 | stomach | .a | 576 to 1173 | 1 to 597 | 597/597 (100 %) | 1 diff (99.9 %id) | |||
BM772454 | stomach | .a | 576 to 1271 | 1 to 695 | 695/695 (100 %) | 1 diff (99.9 %id) | |||
BM825100 | Ascites, stomach | .a | 1059 to 1576 | 534 to 17 | AAA | Submitted on the opposite strand | 518/518 (100 %) | 3 diff (99.5 %id) | |
BM825100 | Ascites, stomach | .a | 1059 to 1576 | 534 to 17 | AAA | Submitted on the opposite strand | 518/518 (100 %) | 3 diff (99.5 %id) | |
BM825741 | Ascites, stomach | .a | 312 to 733 | 1 to 422 | 422/422 (100 %) | 0 diff (100 %id) | |||
BM825741 | Ascites, stomach | .a | 312 to 733 | 1 to 422 | 422/422 (100 %) | 0 diff (100 %id) | |||
BP348533 | brain | .a | 38 to 608 | 1 to 573 | 573/573 (100 %) | 4 diff (99.4 %id) | |||
BP348561 | brain | .a | 38 to 620 | 1 to 583 | 583/583 (100 %) | 13 diff (97.8 %id) | |||
T15892 | .a | 1333 to 1577 | 245 to 1 | 245/294 (83 %) | 1 diff (99.7 %id) | ||||
DR006521 | Spleen | .a | 45 to 752 | 20 to 728 | 709/728 (97 %) | 7 diff (99.1 %id) | |||
DB163113 | thymus | .d-u | 1 to 589 | 2 to 590 | tiling clone, capped | 589/589 (100 %) | 0 diff (100 %id) | ||
TI_149288534 | .a | 877 to 1578 | 805 to 105 | AAA | 701/701 (100 %) | 5 diff (99.3 %id) | |||
TI_149301023 | .a | 718 to 1578 | 935 to 85 | AAA | 851/975 (87 %) | 15 diff (98.5 %id) | |||
TI_154008185 | .a | 911 to 1578 | 807 to 145 | AAA | 663/903 (73 %) | 32 diff (96.5 %id) | |||
TI_154188938 | .b | 121 to 1084 | 46 to 1002 | tiling clone, | 957/1028 (93 %) | 17 diff (98.4 %id) | |||
BM970376 | lung | .a | 942 to 1578 | 655 to 19 | AAA | 637/637 (100 %) | 4 diff (99.4 %id) | ||
BM976987 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .a | 957 to 1578 | 640 to 19 | AAA | 622/622 (100 %) | 0 diff (100 %id) | ||
BM976987 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .a | 957 to 1578 | 640 to 19 | AAA | 622/622 (100 %) | 0 diff (100 %id) | ||
CB243525 | Human Lung Epithelial cells, lung | .a | 854 to 1573 | 737 to 19 | AAA | 719/722 (99 %) | 2 diff (99.8 %id) | ||
CB243525 | Human Lung Epithelial cells, lung | .a | 854 to 1573 | 737 to 19 | AAA | 719/722 (99 %) | 2 diff (99.8 %id) | ||
BM676339 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 1303 to 1575 | 291 to 19 | fully sequenced, AAA | 273/273 (100 %) | 0 diff (100 %id) | ||
BM676339 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 1303 to 1575 | 291 to 19 | fully sequenced, AAA | 273/273 (100 %) | 0 diff (100 %id) | ||
BM712593 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 1014 to 1575 | 1 to 562 | fully sequenced, AAA | 562/562 (100 %) | 0 diff (100 %id) | ||
BM712593 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .a | 1014 to 1575 | 1 to 562 | fully sequenced, AAA | 562/562 (100 %) | 0 diff (100 %id) | ||
BU624141 | cell lines, Enchondroma | .a | 929 to 1577 | 667 to 19 | AAA | 649/649 (100 %) | 1 diff (99.9 %id) | ||
BU624141 | cell lines, Enchondroma | .a | 929 to 1577 | 667 to 19 | AAA | 649/649 (100 %) | 1 diff (99.9 %id) | ||
BU631813 | cell lines, Chondrosarcoma | .a | 1141 to 1578 | 456 to 19 | AAA | 438/438 (100 %) | 9 diff (98.0 %id) | ||
BU631813 | cell lines, Chondrosarcoma | .a | 1141 to 1578 | 456 to 19 | AAA | 438/438 (100 %) | 9 diff (98.0 %id) | ||
BU622988 | cell lines, Chondrosarcoma | .a | 957 to 1576 | 638 to 19 | AAA | 620/620 (100 %) | 0 diff (100 %id) | ||
BU622988 | cell lines, Chondrosarcoma | .a | 957 to 1576 | 638 to 19 | AAA | 620/620 (100 %) | 0 diff (100 %id) | ||
CA432688 | cell lines, Chondrosarcoma | .e-u | 1 to 737 | 754 to 19 | G8X G12V L13S Q14R G15A ... | tiling clone, AAA | 736/736 (100 %) | 2 diff (99.8 %id) | |
CA432688 | cell lines, Chondrosarcoma | .e-u | 1 to 737 | 754 to 19 | G8X G12V L13S Q14R G15A ... | tiling clone, AAA | 736/736 (100 %) | 2 diff (99.8 %id) |
? | Gene Summary | Gene on genome | mRNA:.a, .b, .c, .d-u, .e-u, .f, .g | Alternative mRNAs features, proteins, introns, exons, sequences | Expression Tissue | Function, regulation, related genes CI |